Credit: Getty Images Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a first-degree relative who has DLB, including a 2-fold ...

Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders including dementia with Lewy bodies (DLB), had the opportunity to raise ...

At the International Dementia with Lewy Body Conference, held December 1-4 in Fort Lauderdale, Florida, brain imaging emerged as a promising adjunct to figuring out exactly what is going on in a ...

Marked by degeneration of both the mind and the body, dementia with Lewy bodies (DLB) has for the past 20 years languished on the margins of medical research as an overlooked, mysterious hybrid of ...